Calcium/calmodulin dependent protein kinase II mediates hippocampal glutamatergic plasticity during benzodiazepine withdrawal

Abstract

Benzodiazepine withdrawal-anxiety is associated with potentiation of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor (AMPAR) currents in hippocampal CA1 pyramidal neurons attributable to increased synaptic incorporation of GluA1-containing AMPARs. The contribution of calcium/calmodulin dependent protein kinase II (CaMKII) to enhanced glutamatergic synaptic strength during withdrawal from 1-week oral flurazepam (FZP) administration was further examined in hippocampal slices. As previously reported, AMPAR-mediated miniature excitatory postsynaptic current (mEPSC) amplitude increased in CA1 neurons from 2-day, but not 1-day FZP-withdrawn rats, along with increased single-channel conductance estimated by NSNA. Input-output curve slope was increased without a change in paired-pulse facilitation, suggesting increased AMPAR postsynaptic efficacy rather than altered glutamate release. The increased mEPSC amplitude and AMPAR conductance were related to CaMKII activity, as intracellular inclusion of CaMKIINtide or autocamtide-2 related inhibitory peptide (AIP), but not scrambled peptide, prevented both AMPAR amplitude and conductance changes. mEPSC inhibition by 1-naphthyl acetyl spermine and the negative shift in rectification index at both withdrawal time-points were consistent with functional incorporation of GluA2-lacking AMPARs. GluA1, but not GluA2 or GluA3 levels were increased in immunoblots of postsynaptic density (PSD)-enriched subcellular fractions of CA1 minislices from 1-day FZP-withdrawn rats, when mEPSC amplitude, but not conductance was increased. Both GluA1 expression levels and CaMKIIα–mediated GluA1 Ser⁸³¹-phosphorylation were increased in PSD-subfractions from 2-day FZP-withdrawn rats. Since phospho-Thr²⁸⁶CaMKIIα was unchanged, CaMKIIα may be activated via an alternative signaling pathway. Synaptic insertion and subsequent CaMKIIα-mediated Ser⁸³¹ phosphorylation of GluA1 homomers contribute to benzodiazepine withdrawal-induced AMPAR potentiation and may represent an important hippocampal pathway mediating both drug-induced and activity-dependent plasticity.

Introduction

Benzodiazepines, allosteric modulators of the GABA_A receptor, are a safe, well-tolerated and effective treatment for anxiety, insomnia and seizures, yet carry some abuse liability and signs of physical dependence may emerge after long-term use (Griffiths and Johnson, 2005). While benzodiazepine tolerance has been associated primarily with GABA_A receptor regulation (Bateson, 2002), mechanisms involving both GABAergic and glutamatergic systems have been proposed to underlie manifestations of benzodiazepine dependence (Allison and Pratt, 2003; Wafford, 2005). In fact, pharmacological approaches using specific glutamate receptor antagonists to modify withdrawal phenomena suggested that activation of excitatory amino acid receptors might be central to the expression of benzodiazepine physical dependence (Dunworth and Stephens, 1998; Koff et al, 1997; Van Sickle et al, 2004; Xiang and Tietz, 2007).

Abrupt withdrawal from prolonged benzodiazepine administration results in potentiation of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor (AMPAR)-mediated synaptic currents associated with withdrawal-anxiety (Van Sickle and Tietz, 2002b; Xiang and Tietz, 2007). The amplitude of AMPAR-mediated miniature (m)EPSCs was progressively increased in hippocampal CA1 pyramidal neurons from 1-day and 2-day flurazepam (FZP)-withdrawn rats associated with a localized increase in AMPAR binding (Van Sickle et al, 2002b; Van Sickle et al, 2004) and an increase in glutamate efficacy (Song et al, 2007). Immunofluorescence and immunoblot studies revealed that GluA1 (GluR1, Collingridge et al, 2009), but not GluA2 (GluR2) subunit expression coupled with the enhancement of the GluA1 scaffolding protein, synapse associated protein 97 (SAP97) may be responsible for the enhanced glutamate-elicited currents in CA1 neurons (Song et al, 2007; see also Izzo et al, 2001). The latter interpretation was further supported using postembedding immunogold electron microscopy (EM). GluA1, but not GluA2 immunoreactivity was increased at CA1 neuron asymmetric synapses (Das et al, 2008).

The GluA1 subunit, one of two major hippocampal AMPAR subunits, has a long cytoplasmic carboxyl terminus, which undergoes phosphorylation by several kinases. GluA1 trafficking and phosphorylation contribute to activity-dependent synaptic plasticity (Derkach et al, 2007). In particular, a transient increase in GluA1 AMPARs (Plant et al, 2006) was detected as both a shift in the current rectification index in the presence of spermine analogues (Washburn and Dingledine, 1996) and by an alteration in AMPAR single-channel properties (Benke et al, 1998; Luthi et al, 2004). Calcium/calmodulin dependent protein kinase II (CaMKII), one of the most abundant proteins in the postsynaptic density (PSD), is required for activity-dependent membrane incorporation of GluA1 (and GluA4) subunit-containing AMPARs (Esteban et al, 2003), and subsequent phosphorylation of GluA1-subunits at Ser⁸³¹ enhancing single-channel conductance of GluA2-lacking AMPARs (Derkach et al, 1999; Oh and Derkach, 2005).

To further explore the contribution of CaMKII to AMPAR potentiation during benzodiazepine withdrawal, whole-cell mEPSCs were recorded in CA1 pyramidal neurons in hippocampal slices from rats withdrawn from 1-week oral flurazepam (FZP) administration to evaluate AMPAR-mediated synaptic transmission and single-channel conductance by non-stationary noise analysis (NSNA). Input-output (I/O) relationships and paired-pulse facilitation (PPF) were used in conjunction to assess the contribution of pre- and postsynaptic mechanisms to enhanced AMPAR currents. A potent spermine analogue was applied extracellularly to evaluate the contribution of GluA2-lacking, Ca²⁺-permeable receptors (Pellegrini-Giampietro, 2003; Washburn and Dingledine, 1996) to the transient, progressive, increase in AMPAR potentiation during benzodiazepine withdrawal. Intracellular application of active and inactive CaMKII inhibitors was used to evaluate the role of CaMKII to modify AMPAR conductance. Immunoblots of PSD-enriched subcellular fractions of CA1 minislices were used to evaluate the withdrawal-associated expression patterns of total and phosphorylated GluA1-3 and CaMKIIα/β subunits. The findings suggest that insertion of GluA1 homomeric AMPARs and CaMKII-mediated phosphorylation of Ser⁸³¹GluA1 coupled with enhanced hippocampal AMPAR conductance may represent one common feature among drug-induced and other activity-dependent models of plasticity.

Materials and Methods

FZP-withdrawal Model

A FZP dosing regimen was used which reliably induces manifestations of both benzodiazepine tolerance and dependence in both juvenile and adult rats (Song et al, 2007; Van Sickle and Tietz, 2002b; Van Sickle et al, 2004; Zeng and Tietz, 1999). Male Sprague-Dawley rats (Harlan, Indianapolis, IN), postnatal day (PN) 36-42 at the time of study were handled in accordance with institutional and NIH guidelines and approved by the University of Toledo Institutional Animal Care and Use Committee. Rats were first adapted to the animal facility and to the 0.02% saccharin vehicle for 2-4 days, then offered FZP (provided by the National Institute of Drug Abuse Supply Program) in 0.02% saccharin vehicle for 1 week (100 mg/kg × 3 days; 150 mg/kg × 4 days) as their sole source of drinking water, followed by 1 or 2 days of drug withdrawal. Daily water consumption was monitored to adjust the drug concentration to offer the desired dose. Rats that did not reach a weekly average of 120 mg/kg/day were excluded. FZP-treated rats received saccharin water during the withdrawal period. Matched control rats received the saccharin vehicle in parallel throughout the course of study. All electrophysiological and immunochemical studies described were conducted with the experimenter blind to the experimental treatment groups.

Hippocampal Slice Preparation

Following decapitation, the hippocampus was rapidly dissected and transverse dorsal hippocampal slices (400 μm) were cut on vibratome (Ted Pella, Redding CA) in ice-cold, pre-gassed, low-calcium artificial cerebrospinal fluid (ACSF) containing (in mM): NaCl 120; KCl 2.5; CaCl₂ 0.5; MgCl₂ 7.0; NaH₂PO₄ 1.2; NaHCO₃ 2; D-glucose 20; ascorbate 1.3; pH 7.4. Slices were maintained at room temperature (22°C) for 15 min in gassed low-calcium ACSF and then transferred to normal ACSF containing (in mM): NaCl 119; KCl 2.5; CaCl₂ 1.8; MgSO₄ 1.3; NaH₂PO₄ 1.25; NaHCO₃ 26; D-glucose 10; pH 7.4. Slices recovered at room temperature for ≥ 2 hr in ACSF prior to electrophysiological recording. During recording, slices were perfused at a rate of 2.5 ml/min with gassed ACSF at room temperature.

Whole-cell Electrophysiological Recording

For whole-cell AMPAR-mediated mEPSC recordings, hippocampal slices were continuously perfused with oxygenated ACSF and visualized on an upright Zeiss Axioskop. Blind whole-cell patch-clamp recordings from CA1 pyramidal neurons were made using borosilicate micropipettes (4-7 MΩ, WPI, Sarasota, FL) containing (in mM): Cs methanesulfonate 132.5; CsCl 17.5; HEPES 10; EGTA 0.2; NaCl 8; Mg-ATP 2; Na₃-GTP 0.3; QX-314 2; pH 7.2. Alternately, the CaMKII inhibitor autocamtide-2, a CaMKII substrate (H-KKALRRQETVDAL-OH, 5 μM, EMD Chemicals, Madison, WI) or the more potent, selective CaMKII inhibitor (Ishada et al, 1995) autocamtide-2 inhibitory peptide (H-KKKLRRQEAFDAL-OH, AIP, 5 μM, EMD Chemicals) was added to the micropipette prior to mEPSC recordings. A control scrambled peptide (H-ELRKFQADLKRKA-OH) used at the same micropipette concentration was designed to disrupt both the basic C-terminal and hydrophobic N-terminal groups of AIP. The scrambled sequence was analyzed online using the blastp (protein-protein) suite in the National Center for Biotechnology Information (NCBI) BLAST tool (http://blast.ncbi.nlm.nih.gov/Blast.cgi) and no similar sequence was found in the current database. Since it was more recently shown that CaMKI (Guire et al, 2008), as well as CaMKII (Esteban et al, 2003) can recruit AMPARs to the synapse, the intracellular effects of the most selective CaMKII inhibitor available, CaMKIINtide (5 μM, Sanhueza et al, 2007) was also evaluated in several neurons from control and 2-day FZP-withdrawn rats. EPSCs were recorded under voltage clamp (V_H = -80 mV) in the presence of 1 μM tetrodotoxin (TTX, Alomone Labs, Jerusalem, Israel), 50 μM APV (Tocris Bioscience, Ellisville, MO), 50 μM picrotoxin (Sigma-Aldrich, St. Louis, MO) and 25 μM CGP-35348 (Tocris) in ACSF. Signals were amplified with an Axoclamp2A amplifier coupled to a 4-pole Bessel filter/amplifier (1 kHz, 100×, Cornerstone) and digitized online (20 kHz, Digidata 1200A, Axon), then stored on computer disk for later analysis.

Non-stationary noise analysis

AMPAR single-channel conductance was estimated by offline non-stationary noise analysis (NSNA) of mEPSCs using MiniAnalysis 6.0 (Synaptosoft, Inc, Decatur, GA). Miniature events were detected over 10 min (1-day) or 20 min (2-day) recording. As reported previously, only fast events (10-90% rise time ≤ 3 ms) ≥ 8 pA were used (Shen et al, 2009). All selected events were baseline-adjusted, peak-scaled, superimposed and compared to the peak-scaled mean. The variance of amplitudes during the decay phase was plotted against mean amplitude of mEPSC currents and fitted with the equation: σ² = i* I−I²/N where σ² is the variance of the mEPSC, i indicates the unitary current, I represents the mean of whole-cell current, and N is the total number of channels. The single-channel conductance was calculated by Ohm's law: γ= i/(V_H-V_rev), where V_H is −80 mV and V_rev of AMPAR currents was 0 mV.

Input/output relationship

Evoked AMPAR-mediated EPSCs (eEPSCs, V_H=-80 mV) were induced in the absence of TTX, with a bipolar stimulating electrode placed in the Schaffer collateral pathway. I/O curves were constructed by varying stimulus intensity (V) and measuring peak ESPC current amplitude (pA) from EPSC threshold to spike threshold. The slope of both mean and individual I/O curves was calculated to estimate synaptic efficacy of AMPAR responses.

Paired-pulse facilitation

Stimulus intensity was then adjusted to induce half-maximal responses and paired-pulses were delivered at intervals from 25 ms to 200 ms in 25 ms increments. Paired-pulses were elicited at a frequency of 0.16 Hz. Peak amplitude for individual, paired-pulse responses was measured as the difference between the baseline before the stimulus artifact and the peak eEPSC. PPF was calculated as (EPSC₂-EPSC₁)/EPSC₁ × 100.

Spermine analogue inhibition

Three AMPAR subpopulations are primarily expressed in rat hippocampus, GluA1/2 and GluA2/3 heteromers, and to a lesser extent GluA1 homomers (Moga et al, 2003; Wenthold et al, 1996). Heteromeric GluA2-containing AMPARs exhibit low permeability for divalent cations such as Ca²⁺, whereas GluA2-lacking receptors have high divalent cation permeability (Hollmann et al, 1991). Furthermore, GluA2-containing and GluA2-lacking AMPARs also differ in their pharmacological properties, in particular blockade by extracellularly applied polyamine-containing spider and wasp toxins (Washburn and Dingledine, 1996). To evaluate whether GluA2-lacking receptors were present at CA1 neurons synapses during FZP-withdrawal, 100 μM 1-naphthyl acetyl spermine (NAS, Sigma-Aldrich, St. Louis, MO) was added to the perfusate in the presence of 10 μM APV during AMPAR-mediated (V_H=-80 mV) mEPSC recordings before (10 min) and after (7 min) NAS application. Mean mEPSC amplitude was measured before and after NAS application and the percentage decrease after NAS was calculated.

Furthermore, GluA2-containing AMPARs show linear current-voltage (I-V) relationships or outward rectification, whereas GluA2-lacking AMPAR subunits are prone to spermine blockade and show inward rectification at positive holding potentials (Washburn and Dingledine, 1996). Analogous to recordings in 2-day FZP-withdrawn rats (Song et al, 2007), rectification studies were carried out in hippocampal slices from 1-day FZP withdrawn rats with 100 μM spermine in the micropipette. The rectification index was defined as peak current amplitude at a holding potential of +40 mV divided by that at -60 mV.

Immunoblot Analyses of CA1 Minislices

Subcellular fractionation

For immunoblotting, hippocampi were isolated from 3 matched pairs of control and FZP-withdrawn rats and pooled (21 rats/group; n = 7 wells/group; 2-day GluA1 33 rats/group, n = 11 wells/group; GluA3 (GluR3) and CaMKIIβ 12 rats/group; n = 4 wells/group). The CA1 region was microdissected from the whole hippocampus, then homogenized and centrifuged to obtain a cytosolic fraction (S2), crude membrane pellet (P2) and a PSD-enriched subfraction as previously described (Song et al, 2007). All procedures were conducted at 0-4°C.

Immunoblotting

Protein (15 μg/well) was separated by 10% SDS-PAGE and wet-transferred to nitrocellulose. Primary antibodies anti-GluA1 (1:2,000, Millipore, Billerica, MA), anti-phopho-Ser⁸³¹-GluA1 (1:1,000, Millipore), anti-GluA2 (1:2,000, Millipore), anti-GluA3 (1:100, Millipore,), anti-CaMKIIα (1:5,000, Millipore), anti-phospho-Thr²⁸⁶-CaMKII (1:1,000, Promega Corporation, Madison, WI), anti-CaMKIIβ (1:1,000, Abcam Inc., Cambridge, MA), anti-actin (1:50,000, Millipore) or anti-GAPDH (1:20,000, Abcam Inc.) were incubated with membranes overnight at 4°C. Antibody signals were detected with anti-rabbit or anti-mouse horseradish peroxidase (HRP)-conjugated secondary antibodies (1:10,000, Jackson ImmunoResearch, West Grove, PA), followed by enhanced chemiluminescence (ECL) (Denville Scientific, Metuchen, NJ). Images of immunoblots were scanned and immunoreactivity quantified with ImageJ software, v. 1.36b (National Institutes of Health, Bethesda, MD). GluA or CaMKII subunit signals were normalized to the corresponding GAPDH or actin signal.

Results

Postsynaptic Mechanisms of AMPAR Potentiation during Benzodiazepine Withdrawal

As previously reported (Van Sickle and Tietz, 2002b; Xiang and Tietz, 2007), the amplitude of AMPAR-mediated mEPSCs was significantly increased in CA1 neurons from 2-day FZP-withdrawn rats without effect on mEPSC frequency, rise-time or decay kinetics or resting membrane potential (RMP). I/O experiments confirmed an increased efficacy of synaptic transmission in CA1 neurons from FZP-withdrawn rats. As shown in Fig. 1A, an I/O curve generated by plotting mean evoked EPSC amplitude (pA) versus mean stimulus intensity (V), showed a ∼2.5 fold increase in slope. A similar result (Fig. 1B) was obtained when comparing the mean slope of fits of individual I/O curves (CON, 205.3 ± 44.5 pA/V vs. FZP, 440.0 ± 79.4 pA/V, p<0.05). The potentiation of AMPAR-mediated synaptic transmission reflected in the enhanced slope of the FZP-withdrawn I/O curve paralleled an increase in population spike amplitude (Shen et al, 2009) and in overall CA1 neuron hyperexcitability (Van Sickle et al, 2004) in FZP-withdrawn neurons.

Fig 1.

The slope of the input–output (I/O) relationship, but not paired-pulse facilitation was increased in CA1 neurons from 2-day FZP-withdrawn rats. (A) Evoked EPSC (V_H = -80 mV) amplitude (pA) was plotted as a function of stimulus intensity (V). Linear regression of pooled I/O relationships showed a ∼2.5 fold increase in the stimulus response relationship in CA1 neurons from FZP-withdrawn (open circles, n=9) compared to control (closed circles, n=7) rats. Inset: Representative traces of eEPSCs elicited at 3.6V (solid line: CON; broken line: FZP). Scale as in inset in C. (B) The mean slope of the I/O curve derived from the fits of individual I/O curves generated in neurons from FZP-withdrawn rats (440.0 ± 79.4 pA/V, n=9) was also significantly greater than that from control rats (205.3 ± 44.5 pA/V, n=7). The data are consistent with an increase in CA1 neuron AMPAR synaptic efficacy in FZP-withdrawn rats. Asterisks denote p<.05. (C) Paired-pulse facilitation (PPF) of AMPAR was unchanged in 2-day FZP withdrawn rats. The amplitude of AMPAR-mediated eEPSCs (V_H = -80 mV) following half-maximal stimulation of the Schaffer-collateral pathway. Paired-pulse stimulation was applied and the response was recorded at the inter-stimulus intervals ranging from 25-200 ms in 25 ms increments. Inset: Representative paired EPSC traces recorded in CA1 neurons from control and FZP-withdrawn rats. Paired EPSC amplitudes were calculated as the difference between baseline before the stimulus artifact and EPSC peak. PPF was calculated as (EPSC2-EPSC1)/EPSC1 × 100. Percent facilitation was plotted (CON, closed circles, n = 5; FZP: closed circles, n = 5) and fit with a single exponential decay function. No significant differences between groups were found at any interstimulus interval suggesting that glutamate release onto CA1 neurons was unaltered.

Although mEPSC frequency, which reflects random release of glutamate from presynaptic neurons was not different between groups (Van Sickle and Tietz, 2002b; Van Sickle et al, 2004; Shen et al, 2009), paired-pulse facilitation (PPF) studies were carried out to verify that evoked glutamate release was also not affected during drug withdrawal. Maximal facilitation was observed at the shortest interstimulus interval tested (25 ms) and decayed exponentially with increasing interstimulus intervals (25-200 ms). Consistent with the enhancement of synaptic efficacy in FZP-withdrawn neurons, FZP half-maximal responses tended to be greater than in control rats, yet there were no significant differences in the half-maximal response (CON: 171.5 ± 41.6 pA vs. FZP: 314.3± 69.6 pA, n = 5/group, p = 0.12) or stimulus intensity (CON: 0.34 ± 0.09 V vs. FZP: 0.23 ± 0.04 V, n = 5/group, p = 0.28, Student t-test) used to elicit PPF. There were no significant differences (p=0.23 to 0.94) among PPF responses between experimental groups at any interstimulus interval (Fig. 1C inset: representative traces), reflected in the overlap of the single-exponential decay fits (Fig. 1C). Taken together, the lack of change in mEPSC frequency and PPF, suggests that glutamate release was unchanged between experimental groups excluding presynaptic involvement in benzodiazepine withdrawal-induced AMPAR potentiation.

In models of activity-dependent plasticity, such as long-term potentiation (LTP), CaMKII is primarily activated by Ca²⁺ influx through N-methyl-D-aspartate receptors (NMDARs) (Collingridge et al, 2004) potentiates synaptic efficacy by inducing synaptic insertion of AMPARs, as well as increasing AMPAR single-channel conductance via CaMKII-mediated Ser⁸³¹ GluA1 subunit phosphorylation (Lisman et al, 2002). AMPAR conductance in CA1 neurons from 2-day FZP-withdrawn rats nearly doubled, from 8.5 to 14.7 pS (Shen et al, 2009) an observation that resembled CaMKII-mediated phosphorylation of GluA1 subunits in LTP (Barria et al, 1997b) and modulation of AMPAR conductance in recombinant GluA1 homomeric AMPARs (Derkach et al, 1999). Since mEPSC amplitude was significantly increased in 1-day FZP-withdrawn rats (Van Sickle and Tietz, 2002), NSNA was also used to estimate single-channel conductance at this withdrawal time-point. Unlike in recordings from 2-day withdrawn rats, NSNA analysis of mEPSCs in CA1 neurons from control and 1-day FZP-withdrawn rats confirmed an enhanced AMPAR amplitude (Fig. 2A, CON, 9.4 ± 0.2 pA, n = 6 vs. FZP, 10.3 ± 0.3 pA, n = 7, p = 0.04), without a change in conductance level (Fig. 3B, CON, 11.0 ± 0.6 pS, n =6 vs. FZP, 11.8 ± 1.2 pS, n = 7)

Fig 2.

AMPAR-mediated mEPSC amplitude, but not conductance was increased in 1-day FZP-withdrawn rats. mEPSC amplitude was increased in 1-day FZP withdrawn rats without an effect on mEPSC frequency, rise-time or decay kinetics, or RMP. (A) Representative plot of the results of non-stationary noise analysis (NSNA) of mEPSCs showed an increase in current amplitude, but no change in slope conductance in a FZP-withdrawn (open circles/dotted line) versus a CON (close circles/solid line) neuron. (B) Mean mEPSC conductance in CA1 neurons from CON (closed bars, n= 6) and 1-day FZP-withdrawn (open bars, n= 7) rats indicated no significant difference in AMPAR conductance between experimental groups at this time-point.

Fig 3.

Both AMPAR amplitude and single-channel conductance was reversed by intracellular inclusion of a CaMKII inhibitor. As recorded in ACSF alone (Shen et al., 2009) and as shown in Table 1, mEPSC (A) amplitude and (C) conductance were significantly increased in 2-day FZP-withdrawn rats in the negative control condition, with scrambled autocamtide inhibitory peptide (sAIP) in the whole-cell micropipette. (B) Representative plot of the results of NSNA of mEPSCs showing an increased current amplitude and slope conductance in an FZP-withdrawn neuron with sAIP (open circles/dotted line) versus a CON neuron with sAIP (close circles/black solid line). Intracellular inclusion of the active CaMKII inhibitor, +AIP reversed both the increased AMPAR-mediated mEPSC (A) amplitude and (C) elevated single-channel conductance to control levels (+sAIP) as illustrated in (B) (grey circles/grey solid line). CaMKIINtide inclusion in a few neurons had a similar effect, suggesting that AMPAR potentiation is mediated by CaMKIIα activation.

The enhanced mEPSC amplitude and estimated single-channel conductance in CA1 neurons was consistent with previous findings from both juvenile and adult 2-day FZP-withdrawn rats (Van Sickle and Tietz, 2002, Van Sickle et al, 2004; Shen et al, 2009) and with a CaMKII-mediated mechanism regulating AMPAR potentiation during benzodiazepine withdrawal. Indeed, both effects were eliminated by preincubation (2 hr) of hippocampal slices with the CaMKII inhibitor, KN-93 (Shen et al, 2009). However, since bath-applied KN93 and KN92 can have presynaptic actions and also have effects on L-type voltage-gated Ca²⁺ channels (Gao et al, 2006), the postsynaptic effects of CaMKII on AMPAR potentiation were further evaluated by inclusion of the CaMKII inhibitors, AIP or ACM in the micropipette. sAIP, at the same concentration was used as a negative control. The effects of the more selective inhibitor, CaMKIINtide (Sanhueza et al, 2007) were also evaluated in several control and 2-day FZP-withdrawn neurons. A comparison between neurons recorded in ACSF without sAIP in the micropipette (n=9 cells/ experimental group, Shen et al, 2009) and those in the present study (Table 1) did not reveal any significant differences among control group values. Inclusion of the active peptide, AIP blocked AMPAR potentiation (Fig. 3 and Table 1). That is, both the increased AMPAR-mediated mEPSC amplitude and AMPAR single-channel conductance in neurons from 2-day FZP-withdrawn rats returned to control levels. As shown in Fig. 3 and Table 1, intracellular application of sAIP had no significant effect on mEPSC amplitude (Fig. 3A) or single-channel conductance (Fig. 3C) in FZP-withdrawn vs. control neurons in which mEPSCs remained significantly increased. The estimated single-channel conductance derived from a representative set of recordings from each experimental group is shown in Fig. 3B. The effect of the less-potent CaMKII inhibitor, ACM did not reach statistical significance (Table 1). As with AIP, intracellular inclusion of CaMKIINtide prevented both the increase in peak amplitude (CON: 9.3 ± 1.1 pA, n = 4; FZP: 10.1 ± 2.4 pA, n= 3, p = 0.58) and estimated conductance (CON: 8.9 ± 0.5 pS, n = 4; FZP: 9.6 ± 0.2 pS, n= 3, p = 0.76) without an effect on RMP, rise-time, or tau of decay.

Table 1. mEPSC characteristics after postsynaptic application of CaMKII inhibitors.

Group (# cells)	RMP (mV)	Frequency (Hz)	Rise time (ms)	Amplitude (pA)	Decay tau (ms)	Conductance (pS)
CON
+sAIP (n = 7)	-68.3 ± 1.0	0.23 ± 0.03	3.6 ± 0.3	-8.5 ± 0.2	19.5 ± 1.6	8.6 ± 1.0
+ AIP (n = 6)	-66.0 ± 1.4	0.40 ± 0.09	2.9 ± 0.2	-8.6 ± 0.3	18.2 ± 1.1	10.7 ± 0.9
+ACM (n = 7)	-65.6 ± 1.9	0.30 ± 0.09	3.0 ± 0.2	-8.7 ± 0.2	17.8 ± 0.9	10.4 ± 0.4
FZP
+sAIP (n = 7)	-64.7 ± 1.4	0.35 ± 0.10	3.0 ± 0.2	-9.8 ± 0.2*	17.0 ± 0.6	13.0 ± 1.0**
+ AIP (n = 8)	-67.6 ± 1.9	0.37 ± 0.09	3.2 ± 0.2	-8.6 ± 0.4†	19.5 ± 1.5	9.6 ± 0.9
+ACM (n = 9)	-67.1 ± 2.3	0.27 ± 0.03	3.2 ± 0.1	-9.3 ± 0.3	17.4 ± 1.4	10.8 ± 0.6

Values are listed as means ± S.E.M.

^**p<0.01;

^*p<0.05 (CON+sAIP vs. FZP+sAIP);

^†*p<0.05 (FZP+sAIP vs. FZP+AIP)

GluA2-lacking Receptors Mediate AMPAR Potentiation

Since the number of AMPAR binding sites and of GluA1-, but not GluA2-containing AMPARs was increased at CA1 neuron synapses in FZP-withdrawn rats (Das et al, 2008; Song et al, 2007; Van Sickle and Tietz, 2002b), an enhancement in AMPAR current amplitude was proposed to be due to an increase in the numbers of GluA2-lacking AMPAR numbers. Inward rectification in the presence of spermine or its analogs was therefore used as an electrophysiological tag for the detection of Ca²⁺-permeable, GluA2-lacking AMPAR (Derkach et al, 1999). mEPSCs recorded from CA1 neurons in hippocampal slices from FZP-withdrawn rats showed a decreased +40/-60 rectification index with 100 μM spermine in the micropipette (Song et al, 2007). A similar effect on rectification index was observed in neurons evaluated from 1-day FZP withdrawn rats (FZP, 0.56 ± 0.05, n= 8; CON, 0.81 ± 0.06, n=8, p <0.01). Furthermore as illustrated by its effect on representative average mEPSCs (Fig. 4A and D), extracellular application of NAS, another selective inhibitor of AMPAR currents mediated by GluA2-lacking receptors, had a significantly greater effect to inhibit AMPAR-mediated mEPSC amplitude in CA1 neurons from 1 and 2-day FZP-withdrawn vs. control rats (Fig. 4B and E). Removing the synaptic current component mediated by Ca²⁺-permeable AMPARs with NAS also abolished the potentiation of mEPSC amplitude in neurons from FZP-withdrawn rats (Fig. 4C and F) (1-day: FZP, 10.3 ± 0.3 pA vs. FZP + NAS, 8.3 ± 0.4 pA, n=7, p = 0.002; 2-day: FZP, 10.6 ± 0.3 pA vs. FZP + NAS, 8.4 ± 0.4 pA, n=12, p < 0.0001). The effect was might be smaller in control neurons since GluA1 homomers make up less than 10% of AMPARs (1-day: CON, 9.4 ± 0.2 pA vs. CON + NAS, 8.5 ± 0.2 pA, n=6, p = 0.01; 2-day: CON, 9.0 ± 0.3 pA vs. CON + NAS, 8.1 ± 0.4 pA, n=7, p = 0.10). This finding lent further support to the hypothesis that AMPAR potentiation during drug withdrawal was mediated by incorporation of GluA2-lacking AMPAR into CA1 neuron synapses.

Fig 4.

Greater NAS inhibition in neurons from 1- and 2-day FZP-withdrawn rats. Representative AMPAR-mediated mEPSCs (A, 1-day; D, 2-day) recorded before (solid line) and after (dotted line) external application of the potent spermine analogue, NAS (100 μM). The percent NAS inhibition of mEPSC current amplitude was increased (B, 1-day; E, 2-day) in CA1 neurons from FZP-withdrawn rats (p<0.05). Bath application of NAS abolished the increased AMPAR-mediated mEPSC amplitude in FZP-withdrawn neurons after 1-day (n= 7) and 2-days (n=12) and was without effect in control neurons (1-day, n= 6; 2-days, n=7), supporting the hypothesis that AMPAR current potentiation is mediated by synaptic incorporation of GluA2-lacking AMPARs. Asterisks denote * p≤.05 or ** p≤.01.

Expression Pattern of GluA and CaMKII Subunits in PSD-enriched Subcellular Fractions

Electrophysiological findings in 1-day and 2-day FZP-withdrawn rats (Figs. 2 and 3, Van Sickle et al, 2004; Shen et al, 2009) suggested that synaptic incorporation of GluA1-containing AMPAR may mediate the increase in mEPSC amplitude and that subsequent CaMKII-mediated phosphorylation of Ser⁸³¹GluA1 may mediate enhanced AMPAR conductance. Therefore, total and phospho(p)Ser⁸³¹GluA1 subunit levels were examined by immunoblot analysis of subfractionated proteins in PSD-enriched subcellular fractions of CA1 minislices from 1-day and 2-day FZP withdrawn rats. GluA1 and pSer⁸³¹GluA1 expression levels in the cytosolic (S2) and crude membrane (P2) subfractions (data not shown) were unchanged after 2-day withdrawal. However, total GluA1 expression levels in the PSD-enriched subfraction were elevated in both 1-day and 2-day FZP-withdrawn subfractions (Fig. 5A and B), as reported previously after 2-days (Song et al, 2007). As in 2-day FZP-withdrawn tissues (Das et al, 2008; Song et al, 2007), GluA2 subunit protein levels were also unchanged in 1-day FZP-withdrawn subfractions (Fig. 5B). As shown in the lower panels in Fig. 5B, pSer⁸³¹GluA1 subunit levels were elevated in PSD-enriched subfractions in 2-day, but not 1-day FZP-withdrawn subfractions (Fig. 5A), consistent with an increase in AMPAR conductance in neurons from 2-day (Fig. 3, Shen et al, 2009), but not 1-day FZP-withdrawn rats (Fig. 2).

Fig 5.

GluA subunit levels in CA1 PSD-enriched subcellular fractions as a function of time after drug withdrawal. PSD-enriched subfractions were collected by ultracentrifugation of TritonX-100-resistant membranes pooled from 3 hippocampal CA1 minislices as described in the methods. Representative immunoblots of total GluA1 and pSer⁸³¹GluA1 with their respective loading controls are shown in PSD-enriched subfractions from (A) 1-day and (B) 2-day FZP-withdrawn rats in the leftmost panels. Histograms of integrated signal density as a percent of paired control density (n=4-11 lanes/group) are shown to the right. Only total-GluA1 expression levels were significantly enhanced in 1-day FZP withdrawn rats, while both total and pSer⁸³¹GluA1 levels were increased in 2-day FZP withdrawn rats. There were no changes in GluA2 levels in 1-day (or 2-day, Das et al, 2008; Song et al, 2007) FZP-withdrawn rats. There were also no changes in GluA3 expression levels in the PSD-enriched fraction from 2-day FZP withdrawn rats. Asterisks denote p<.05.

The increased expression of GluA1 subunits in CA1 minislices from 1-day FZP-withdrawn rats provides support for the proposal that GluA1-containing AMPARs were incorporated into CA1 synapses prior to Ser⁸³¹ phosphorylation by CaMKII resulting in a subsequent functional increase in AMPAR single channel conductance (Oh and Derkach, 2005). Nonetheless, benzodiazepine withdrawal-induced Ca²⁺-permeable AMPAR complexes could include GluA1 and GluA3 homomers or additionally GluA1/GluA3 heteromers, a composition that cannot be pharmacologically distinguished by NAS-mediated blockade (Fig. 4). Thus as an initial step to distinguish among these possibilities, GluA3 subunit levels were also assessed in 2-day FZP-withdrawn minislices. Fig. 6B shows that GluA3 subunit levels were unchanged in the PSD-enriched subfraction from 2-day FZP-withdrawn minislices. These data suggest that GluA3-containing AMPAR did not contribute to the shift in inward rectification index (Song et al, 2007) or to enhanced Ca²⁺-permeable AMPAR currents (Fig. 4), thus did not play a role to enhance excitatory synaptic transmission in FZP-withdrawn neurons. Taken together, these data provide further support for the interpretation that AMPAR potentiation is related to synaptic incorporation and phosphorylation of GluA1 homomers.

Fig 6.

CaMKII subunit levels in CA1 PSD-enriched subcellular fractions as a function of time after drug withdrawal. Representative immunoblots of total CaMKIIα, pThr²⁸⁶-CaMKIIα and CaMKIIβ protein with their respective GAPDH loading controls are shown in PSD-enriched subfractions of CA1 minislices from (A) 1-day and (B) 2-day FZP-withdrawn rats in the leftmost panels. Histograms of integrated signal density as a percent of the paired control density (n=4-7 lanes/group) are shown to the right. Total-CaMKIIα expression levels were significantly increased in 2-day FZP-withdrawn rats. No significant changes in pThr²⁸⁶-CaMKIIα or CaMKIIβ expression levels were found. Asterisks denote p<.05.

Because Ser⁸³¹ GluA1 has been identified as a substrate of CaMKII (Barria et al, 1997a; Mammen et al, 1997) and can be phosphorylated by the constitutively active form, phospho(p)Thr²⁸⁶-CaMKII, the expression levels of total- and pThr²⁸⁶-CaMKII were also examined in all subfractions derived from 1-day and 2-day FZP-withdrawn minislices. Total CaMKII protein levels were significantly, and ubiquitously increased in all three subfractions (S2, P2: data not shown) and PSD-enriched subfractions from 2-day, but not 1-day FZP-withdrawn CA1 minislices (Fig. 6A and B) providing a possible mechanism for Ser⁸³¹ phosphorylation of AMPAR GluA1 subunits at the latter withdrawal time-point. But unlike changes in pThr²⁸⁶-CaMKII associated with LTP induction (Lisman et al, 2002; Bayer et al, 2006), expression levels of the constitutively active form of CaMKII were unchanged at both time-points after drug withdrawal (Fig. 6A and B). Since a small fraction of CaMKIIβ can dock the more prevalent, CaMKIIα to the actin cytoskeleton (Shen et al, 1998), CaMKIIβ levels were also compared in these PSD-enriched subfractions. There were no significant differences in CaMKIIβ expression in the PSD-enriched subfraction derived from 2-day FZP-withdrawn minislices (Fig. 6B).

Discussion

Enhanced AMPAR Postsynaptic Efficacy

A significant link was previously established between the increased efficacy of hippocampal CA1 pyramidal neuron AMPAR-mediated glutamatergic synaptic transmission and withdrawal-induced anxiety-like behavior (Van Sickle et al, 2004; Xiang and Tietz, 2007), consistent with findings in other benzodiazepine-withdrawal models (Allison and Pratt, 2003; Izzo et al, 2001) and other animal models of anxiety (Shen et al, 2007). The enhancement of macroscopic glutamate currents and increased AMPAR-mediated mEPSC amplitude in the absence of a change in glutamate affinity or current desensitization was attributable to increased GluA1-, but not GluA2-containing AMPARs at CA1 neuron synapses (Das et al, 2008; Song et al, 2007). Along with previous findings in hippocampal slices (Van Sickle and Tietz, 2002; Van Sickle et al, 2004), the ∼2.5-fold increased slope of the I/O relationship confirmed that AMPAR-mediated synaptic transmission was potentiated in 2-day FZP-withdrawn rats (Fig. 1A and B). A similar effect was noted in lateral amygdala slices of fear-conditioned rats (McKernan and Shinnick-Gallagher, 1997). However, unlike in the latter model of emotional learning, presynaptic facilitation of glutamate release was not observed (Fig. 1C) and mEPSC frequency was unaltered in FZP-withdrawn rats (Shen et al, 2009; Van Sickle and Tietz, 2002; Van Sickle et al, 2004). In common with current views of mechanisms underlying LTP (Nicoll, 2003), a presynaptic mechanism is not likely central to drug-induced glutamatergic plasticity.

Though previous experiments showed that bath application of hippocampal slices with the CaMKII inhibitor, KN-93 could prevent AMPAR potentiation during 2-day FZP withdrawal (Shen et al, 2009), a presynaptic mechanism could not be excluded since CaMKII can also modulate neurotransmitter vesicle release (Llinas et al, 1985; Margrie et al, 1998). To rule out presynaptic effects of CaMKII inhibition, various CaMKII inhibitors were included in the micropipette. Intracellular inclusion of AIP, but not the scrambled peptide, as well as CaMKIINtide had a similar effect as the less selective bath-applied inhibitor to prevent potentiation of AMPAR synaptic currents and conductance (Shen et al, 2009). These findings provide strong evidence that postsynaptic CaMKII activation is involved in CA1 neuron hyperexcitability. As with LTP, enhancing CaMKIIα activity can lead to synaptic delivery of GluA1-containing AMPARs, an increase in mEPSC quantal size and enhanced AMPAR conductance in hippocampal neurons and heterologous systems (Poncer et al, 2002; Oh and Derkach, 2005). Accordingly, an increase in trafficking and subsequent CaMKII-mediated phosphorylation of GluA1-containing AMPARs (Barria et al, 1997b; Derkach et al, 1999; Esteban et al, 2003; Hayashi et al, 2000) offered a possible molecular basis for synaptic AMPAR potentiation associated with benzodiazepine withdrawal.

Incorporation of homomeric GluR1 AMPAR

GluA1/2 heteromers represent a large portion (∼80%) of native synaptic CA1 neuron AMPARs and GluA2/3 heteromers a dominant fraction of the remainder (Lu et al, 2009; Wenthold et al, 1996). GluA1/3 heteromers are rare in the presence of GluA2 subunits (Moga et al, 2003; Sans et al, 2003; Wenthold et al, 1996). GluA4 (GluR4) subunit expression is largely confined to the first postnatal week (Zhu et al, 2000). A small proportion (∼8%) of native AMPAR complexes were proposed to exist as GluA1 homomers (Wenthold et al, 1996), the small number of CA1 GluA1 homomers resides intracellularly or on non-pyramidal neurons. The intracellular subpopulation is trafficked to the CA1 synapse immediately upon a reduction in GluA2 expression (Lu et al, 2009). Q/R site editing, complete (>99%) at all stages of development (Seeburg, 1996) renders AMPAR containing even a single GluA2 subunit Ca²⁺ impermeable and insensitive to spermine block, while GluA2-lacking AMPARs show inward rectification (Pellegrini-Giampietro, 2003; Washburn and Dingledine, 1996, Swanson et al., 1997). Native CA1 neurons exhibit largely linear to outward rectification in response to AMPA (Lerma et al, 1994; Song et al, 2007). The shift in the rectification index in 2-day FZP-withdrawn neurons (Song et al, 2007) was supportive evidence for functional incorporation of synaptic Ca²⁺ permeable GluA1-containing AMPARs (Esteban et al, 2003; Shi et al, 1999), though could not exclude an increase in GluA3 homomers or GluA1/3 heteromers (Moga et al, 2003; Pellegrini-Giampietro, 2003). The lack of change in GluA3 expression (Fig 5B) in 2-day withdrawn CA1 PSD-subfractions added support for the interpretation that GluA1-homomers are incorporated into excitatory synapses. The significant increase in spermine analogue (NAS) inhibition of mEPSCs in both 1-day and 2-day FZP-withdrawn neurons (Fig. 4) also supported an increased proportion of incorporation of GluA2-lacking AMPARs, rather than GluA1/2 heteromers into CA1 synapses at both withdrawal time-points.

A Two-Step Process: GluR1 Subunit Incorporation and Phosphorylation

AMPA receptors in CA1 neurons have multiple conductance states (Benke et al, 1998; Swanson et al, 1997). AMPAR conductance (γ) at CA1 synapses was estimated to be 7.7 pS, the range (1.5 to 22.3 pS, PN13-15) related to synaptic variation. Glutamate has concentration-dependent effects to increase AMPAR channel conductance (Gebhardt and Cull-Candy, 2006) and synaptic concentrations (1 mM) applied to outside-out CA1 dendritic patches revealed a mean conductance of 10.2 pS, despite their low calcium permeability (P_Ca2+/Cs+ ∼0.5) (Spruston et al, 1995, PN13-28). Very low conductance channels (∼300 fS), attributable to fully RNA-edited GluA2-containing receptors in native assemblies (Seeburg, 1996) reduced the weighted mean conductance (Swanson et al, 1997). GluA2-containing receptors expressed in HEK-293 cells had conductances of ∼2-3 pS (Oh and Derkach, 2005). while 9 and 14 pS conductance states dominated GluA1 homomers, representing 85% of channel openings. Co-expression of CaMKII, GluA1 Ser⁸³¹ phosphorylation or mutation of Ser⁸³¹ to Asp, increased the occurrence of far less frequent, higher conductance states (21 and 28 pS, Derkach et al., 1999, Oh and Derkach, 2005). Importantly, the latter increased GluA1 conductance was only functionally expressed in the absence of assembled GluA2 subunits (Oh and Derkach, 2005). These findings imply that a subpopulation of primarily Ca²⁺ impermeable GluA2-containing AMPARs, including extrasynaptic somatic receptors (Lerma, et al, 1994; Lu et al, 2009) with lower conductance states offsets a mixed population of higher conductance state dendritic AMPARs, each making a contribution to the whole-cell weighted mean conductance (Benke et al, 1998; Spruston et al, 1995).

The mean conductance derived from NSNA analysis of mEPSCs in CA1 neurons from control and 2-day FZP-withdrawn rats (Table 1, PN36-42), was comparable to that previously observed in this model (Shen et al, 2009). Since GluA1, but not GluA2 subunit expression was not increased in 1-day FZP-withdrawn rats (Fig. 5) and glutamate affinity was unchanged during FZP withdrawal (Song et al, 2007), the increased mEPSC amplitude likely reflected the increased insertion of homomeric GluA1-containing AMPARs at CA1 neuron synapses (Das et al, 2008). If a small number of newly contributing GluA1 homomers with a higher conductance state (9-14 pS, Derkach et al, 1999) were inserted into the synapse, this might result in the small, but significant increase in current amplitude without an observable change in the estimated conductance of native receptors in 1-day FZP- withdrawn compared to matched control rats (Benke et al, 1998; Spruston et al, 1995). Furthermore, the evidence suggests that CaMKII phosphorylation of GluA1 Ser⁸³¹ was responsible for the near doubling of estimated channel conductance observed in neurons from 2-day FZP-withdrawn rats (Fig. 6, Table 1).

Interestingly, in a model of CaMKII-mediated AMPAR recruitment, Guire et al (2008) calculated that for a typical CA1 hippocampal synapse containing ∼90 GluA2-containing AMPARs, recruitment and phosphorylation of just four GluA1 homomers was sufficient to increase synaptic strength by 80%. Since the number of AMPAR at the CA1 postsynaptic density was estimated to be ∼58-70 (Spruston et al, 1995), the 51-73% increase in synaptic strength associated with benzodiazepine withdrawal-anxiety would be consistent with the observed incorporation of GluA1, but not GluA2 subunits into CA1 neuron synapses (Das et al, 2008), and based on the latter model of AMPAR potentiation (Guire et al, 2008) would represent incorporation of just ∼2-3 GluA homomeric receptors/synapse (Shen et al, 2009). Collectively, the functional data suggested that AMPAR potentiation may be modified in a stepwise fashion during drug withdrawal, involving the progressive insertion of GluA1 homomers in 1-day FZP-withdrawn rats, possibly via PKA-mediated phosphorylation of Ser⁸⁴⁵ (Lee et al, 2010; He et al, 2009; Esteban et al, 2003; Song and Tietz, 2004), followed by enhanced GluA1 phosphorylation of Ser⁸³¹ and a shift toward higher AMPAR conductance states on day 2 after withdrawal (Derkach et al., 1999; Esteban et al, 2003; Oh and Derkach, 2005).

To provide further insight into possible mechanisms by which AMPAR currents were potentiated during the withdrawal phase, the time-course of GluA and CaMKII subunit expression patterns and their relevant phospho- analogues was evaluated in PSD-enriched subfractions of CA1 minislices. Since GluA1, but not GluA2 or GluA3 subunit expression was enhanced (Fig. 5, see also Izzo et al, 2001), the immunoblot findings were consistent with the hypothesis that GluA1 homomers were incorporated into CA1 neurons from 1-day FZP-withdrawn rats, leading to increased AMPAR current amplitude, similar to that observed with LTP (Lledo et al, 1995; Barria et al., 1997b; Benke et al, 1998; Plant et al, 2006), though see also Adesnik and Nicoll, 2007). Interestingly, early LTP induced by theta burst stimulation was not maintained in slices from 2-day FZP-withdrawn rats, though behavioral effects on novel object recognition, and place and contextual memory were not observed (Shen et al, 2009). Since AMPAR potentiation was also mutually occluded by CaMKII activation or tetanic stimulation (Lledo et al, 1995; Wang and Kelly, 1995), the latter finding further suggests that LTP- and drug-induced plasticity may share a similar downstream CaMKII-mediated pathways.

Convergence/Divergence of Plasticity Models

The mechanisms by which AMPAR currents are potentiated during drug withdrawal and with other models of activity-dependent plasticity show numerous common features, though some notable dissimilarities. Unlike LTP, in which autophosphorylation of Thr²⁸⁶ leads to constitutive activation of CaMKIIα without a change in total CaMKIIα expression (Barria et al, 1997b; Lisman et al, 2002), pThr²⁸⁶-CaMKII levels remained unchanged in PSD-enriched subfractions derived from 1-day or 2-day FZP-withdrawn rats. On the contrary, the total CaMKIIα expression level was enhanced in all subcellular fractions from 2-day FZP-withdrawn rats (Fig. 6), while CaMKIIβ expression was unchanged in the PSD-enriched subfraction. Phosphorylation of Ser⁸³¹GluA1, in the face of enhanced CaMKIIα levels suggests that CaMKIIα levels in drug-withdrawn neurons might be autonomously-activated through an alternate mechanism, e.g. binding to the GluN2B subunit (Bayer et al, 2001, Bayer et al, 2006). Notably, expression of withdrawal-anxiety can be modulated in 2-day FZP-withdrawn rats via depression of NMDAR function (Van Sickle et al, 2002; Van Sickle et al, 2004). Moreover, preliminary immunoblot and EM findings indicate that depression of NMDAR function involves a reduction in GluN1/GluN2B receptors at CA1 neuron synapses (Shen et al, 2008; Das et al, 2009). Distinct from NMDAR-dependent LTP, in which Ca²⁺ influx primarily through NMDAR initiates CaMKII activation and AMPAR potentiation (Barria et al, 1997b, Collingridge et al, 2004), Ca²⁺ entry during benzodiazepine withdrawal may primarily occur via an increase in high voltage-activated Ca²⁺ channel current density (Katsura et al, 2007; Van Sickle et al, 2004; Xiang et al, 2008; Xiang and Tietz, 2007) and perhaps subsequently, via the increased density of Ca²⁺-permeable, GluA1 homomeric AMPARs (Das et al, 2008; Song et al, 2007).

The findings in benzodiazepine-withdrawn rats extend previous studies, which reported that regulation of GluA1-containing AMPARs plays a significant role in a variety of models of drug-induced plasticity associated with drug abuse (Loweth et al, 2010; Anderson et al, 2008; Kauer and Malenka, 2007; Boudreau and Wolf 2005; Wolf et al, 2004; Sutton et al, 2003; Fitzgerald et al, 1996). GluA1 subunit alterations were detected in the mesolimbic dopamine reward system including prefrontal cortex and related limbic areas such as hippocampus and amygdala following withdrawal from repeated administration of a variety of drugs of abuse including opioids, cocaine and ethanol (Ortiz et al, 1995; Glass et al, 2005, 2008; Ghasemzadeh et al, 2009; Edwards et al, 2009;). For instance, behavioral sensitization which develops during withdrawal from repeated cocaine administration was recently associated with enhanced surface GluA1 expression in nucleus accumbens, without increased phospho-CaMKIIα levels (Boudreau et al, 2009), consistent with the observation that pThr²⁸⁶-CaMKII expression was unchanged during benzodiazepine withdrawal, despite enhanced GluA1 homomer Ser⁸³¹ phosphorylation. Moreover, as in benzodiazepine-withdrawn rodents associated with signs of physical dependence (Katsura et al, 2007; Xiang et al, 2008), cocaine sensitization was also associated with an enhancement of Ca²⁺ entry through L-type voltage-gated Ca²⁺ channels (Nasif et al, 2005; Ford et al, 2009). Accordingly, the sources of Ca²⁺ entry during drug withdrawal, the resultant effect on CaMKIIα activation and, in turn AMPAR potentiation in specific brain areas might in part explain the differences detected among models of activity dependent and drug-induced plasticity. That is, upstream mechanisms of CaMKII activation may differ between models of activity-dependent plasticity resulting from brief, coincident activation of excitatory pathways, such as in LTP or fear-conditioning (McKernan and Shinnick-Gallagher, 1997; Rodrigues et al, 2004) in comparison to drug-induced plasticity resulting from more persistent, selective activation of drug targets in specific neural circuits.